- Home
- IMTE vs TCRT Comparison
IMTE vs TCRT Comparison
Compare IMTE & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- TCRT
- Stock Information
- Founded
- IMTE 2008
- TCRT 1998
- Country
- IMTE Malaysia
- TCRT United States
- Employees
- IMTE N/A
- TCRT N/A
- Industry
- IMTE Consumer Electronics/Appliances
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- TCRT Health Care
- Exchange
- IMTE Nasdaq
- TCRT Nasdaq
- Market Cap
- IMTE 3.3M
- TCRT 3.9M
- IPO Year
- IMTE N/A
- TCRT N/A
- Fundamental
- Price
- IMTE $1.00
- TCRT $1.77
- Analyst Decision
- IMTE
- TCRT
- Analyst Count
- IMTE 0
- TCRT 0
- Target Price
- IMTE N/A
- TCRT N/A
- AVG Volume (30 Days)
- IMTE 30.5K
- TCRT 308.7K
- Earning Date
- IMTE 10-21-2025
- TCRT 08-14-2025
- Dividend Yield
- IMTE N/A
- TCRT N/A
- EPS Growth
- IMTE N/A
- TCRT N/A
- EPS
- IMTE N/A
- TCRT N/A
- Revenue
- IMTE $123,337.00
- TCRT $6,000.00
- Revenue This Year
- IMTE N/A
- TCRT $5,680,500.00
- Revenue Next Year
- IMTE N/A
- TCRT N/A
- P/E Ratio
- IMTE N/A
- TCRT N/A
- Revenue Growth
- IMTE 4.75
- TCRT N/A
- 52 Week Low
- IMTE $0.51
- TCRT $1.31
- 52 Week High
- IMTE $3.17
- TCRT $6.20
- Technical
- Relative Strength Index (RSI)
- IMTE 46.33
- TCRT 24.52
- Support Level
- IMTE $0.92
- TCRT $2.23
- Resistance Level
- IMTE $1.02
- TCRT $2.44
- Average True Range (ATR)
- IMTE 0.06
- TCRT 0.34
- MACD
- IMTE 0.00
- TCRT -0.04
- Stochastic Oscillator
- IMTE 45.71
- TCRT 6.76
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.